The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 1033-1040

  Kazantseva, A ^a   Gaysina, D ^a,b   Malykh, S ^c   Khusnutdinova, E ^a  

^a INSTITUTE OF BIOCHEMISTRY AND GENETICS   (Russian Federation)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c INSTITUTE OF DEVELOPMENTAL PHYSIOLOGY   (Russian Federation)

Author keywords

Association; Dopamine; Personality; Psychobiological model; Sex

Indexed keywords

ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1 PROTEIN; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; PROTEIN SLC6A3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANKK1 GENE; ARTICLE; CAUCASIAN; DRD2 GENE; ETHNICITY; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; MALE; PERSONALITY; RUSSIAN FEDERATION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A3 GENE; TEMPERAMENT AND CHARACTER INVENTORY 125; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; DNA; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MINISATELLITE REPEATS; PERSONALITY; PERSONALITY TESTS; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; PSYCHOMETRICS; RECEPTORS, DOPAMINE D2; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RUSSIA; SEX CHARACTERISTICS;

EID: 79955986953     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.02.013     Document Type: Article

References (92)

1. Becker J.B. Gender differences in dopaminergic function in striatum and nucleus accumbens. Pharmacol Biochem Behav 1999, 64(4):803-812.
2. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Methodol 1995, 57(1):289-300.
3. Berggren U., Fahlke C., Aronsson E., Karanti A., Eriksson M., Blennow K., et al. The taqI DRD2 A1 allele is associated with alcohol-dependence although its effect size is small. Alcohol Alcohol 2006, 41(5):479-485.
4. Berman S., Ozkaragoz T.Z., Young R.M., Noble E. D2 dopamine receptor gene polymorphism discriminates two kinds of novelty seeking. Pers Individ Diff 2002, 33:867-882.
5. Biederman J., Kim J.W., Doyle A.E., Mick E., Fagerness J., Smoller JW., et al. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet 2008, 147B(8):1511-1518.
6. Brookes K.J., Neale B.M., Sugden K., Khan N., Asherson P., D'Souza UM. Relationship between VNTR polymorphisms of the human dopamine transporter gene and expression in post-mortem midbrain tissue. Am J Med Genet B Neuropsychiatr Genet 2007, 144B(8):1070-1078.
7. Chen W.J., Lu M.L., Hsu Y.P., Chen CC., Yu JM., Cheng AT. Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. Am J Med Genet 1997, 74(2):129-136.
8. Cloninger C.R., Svrakic D.M., Przybeck T.R. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993, 50:975-990.
9. Comings D.E., Rosenthal R.J., Lesieur H.R., Rugle LJ., Muhleman D., Chiu C., et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996, 6(3):223-334.
10. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Blake H., et al. A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin Genet 2000, 58:375-385.
11. Conner B.T., Hellemann G.S., Ritchie T.L., Noble E.P. Genetic, personality, and environmental predictors of drug use in adolescents. J Subst Abuse Treat 2010, 38(2):178-190.
12. Connor JP, Young RM, Saunders JB, Lawford BR, Ho R, Ritchie TL, et al. The A1 allele of the D2 dopamine receptor gene region, alcohol expectancies and drinking refusal self-efficacy are associated with alcohol dependence severity. Psychiatry Res 2008;160(1):94-105.
13. Costa P.T., Herbst J.H., McCrae R.R., Siegler IC. Personality at midlife: stability, intrinsic maturation, and response to life events. Assessment 2000, 7:365-378.
14. Dalley J.W., Fryer T.D., Brichard L., Robinson ES., Theobald DE., Lääne K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315(5816):1267-1270.
15. Di Chiara G., Bassareo V., Fenu S., De Luca MA., Spina L., Cadoni C., et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004, 47(Suppl 1):227-241.
16. Drtilkova I., Sery O., Theiner P., Uhrova A., Zackova M., Balastikova B., et al. Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett 2008, 29(3):320-327.
17. Eisenberg D.T., Campbell B., Mackillop J., Lum JK., Wilson DS. Season of birth and dopamine receptor gene associations with impulsivity, sensation seeking and reproductive behaviors. PLoS ONE 2007, 2(11):e1216.
18. Epperson C.N. Postpartum major depression: detection and treatment. Am Fam Physician 1999, 59(8):2247-2254. 2259-2260.
19. Feng Y., Wigg K.G., Makkar R., Ickowicz A., Pathare T., Tannock R., et al. Sequence variation in the 3'-untranslated region of the dopamine transporter gene and attention-deficit hyperactivity disorder (ADHD). Am J Med Genet B Neuropsychiatr Genet 2005, 139(1):1-6.
20. Forger N.G. The organizational hypothesis and final common pathways: sexual differentiation of the spinal cord and peripheral nervous system. Horm Behav 2009, 55(5):605-610.
21. Fuke S., Suo S., Takahashi N., Koike H., Sasagawa N., Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001, 1(2):152-156.
22. Gabriel S.B., Schaffner S.F., Nguyen H., Moore JM., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
23. Galili-Weisstub E., Levy S., Frisch A., Gross-Tsur V., Michaelovsky E., Kosov A., et al. Dopamine transporter haplotype and attention-deficit hyperactivity disorder. Mol Psychiatry 2005, 10(7):617-618.
24. Giros B., Caron M.G. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993, 14(2):43-49.
25. Grandy D.K., Litt M., Allen L., Bunzow JR., Marchionni M., Makam H., et al. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989, 45(5):778-785.
26. Greenwood T.A., Schork N.J., Eskin E. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 2006, 11(2):125-133.
27. Grucza R.A., Goldberg L.R. The comparative validity of 11 modern personality inventories: predictions of behavioral acts, informant reports, and clinical indicators. J Pers Assess 2007, 89:167-187.
28. Hayden E.P., Klein D.N., Dougherty L.R., Olino T.M., Laptook R.S., Dyson M.W., et al. The dopamine D2 receptor gene and depressive and anxious symptoms in childhood: associations and evidence for gene-environment correlation and gene-environment interaction. Psychiatr. Genet. 2010, 20(6):304-310.
29. Hamajima N., Ito H., Matsuo K., Saito T., Tajima K., Ando M., et al. Association between smoking habits and dopamine receptor D2 taqI A A2 allele in Japanese males: a confirmatory study. J Epidemiol 2002, 12(4):297-304.
30. Hietala J., Pohjalainen T., Heikkilä-Kallio U., West C., Salaspuro M., Syvälahti E. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiatr Genet 1997, 7(1):19-25.
31. Hirvonen MM, Lumme V, Hirvonen J, Pesonen U, Någren K, Vahlberg T, et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(4):630-6.
32. Hoenicka J., Quiñones-Lombraña A., España-Serrano L., Alvira-Botero X., Kremer L., Pérez-González R., et al. The ANKK1 gene associated with addictions is expressed in astroglial cells and upregulated by apomorphine. Biol Psychiatry 2010, 67(1):3-11.
33. Hou Q.F., Li S.B. Potential association of DRD2 and DAT1 genetic variation with heroin dependence. Neurosci Lett 2009, 464(2):127-130.
34. Hirvonen J., van Erp T.G., Huttunen J., et al. Striatal dopamine D1 and D2 receptor balance in twins at increased genetic risk for schizophrenia. Psychiatry Res 2006, 146(1):13-20.
35. Huang S.Y., Lin W.W., Wan F.J., ang AJ., Ko HC., Wang TJ., et al. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 2007, 32(3):185-192.
36. Hull E.M., Lorrain D.S., Du J., et al. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav Brain Res 1999, 105(1):105-116.
37. Hutchison K.E., Stallings M., McGeary J., Bryan A. Population stratification in the candidate gene study: fatal threat or red herring?. Psychol Bull 2004, 130(1):66-79.
38. Ishiguro H., Arinami T., Saito T., Akazawa S., Enomoto M., Mitushio H., et al. Association study between the -141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 1998, 22(4):845-848.
39. Joe K.H., Kim D.J., Park B.L., Yoon S., Lee HK., Kim TS., et al. Genetic association of DRD2 polymorphisms with anxiety scores among alcohol-dependent patients. Biochem Biophys Res Commun 2008, 371(4):591-595.
40. Jönsson E.G., Nöthen M.M., Grünhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999, 4(3):290-296.
41. Kaasinen V., Nagren K., Hietala J., Farde L., Rinne JO. Sex differences in extrastriatal dopamine d(2)-like receptors in the human brain. Am J Psychiatry 2001, 158(2):308-311.
42. Khusnutdinova E., Bermisheva M., Kutuev I., Yunusbayev B., Villems R. Genetic landscape of the central Asia and Volga-Ural region. Biosphere origin and evolution 2007, 373-382. Springer, New York. N. Dobretsov, N. Kolchanov, A. Rozanov (Eds.).
43. Köhnke M.D., Batra A., Kolb W., Köhnke AM., Lutz U., Schick S., et al. Association of the dopamine transporter gene with alcoholism. Alcohol Alcohol 2005, 40(5):339-342.
44. Laakso A., Vilkman H., Kajander J., Bergman J., Paranta M., Solin O., et al. Prediction of detached personality in healthy subjects by low dopamine transporter binding. Am J Psychiatry 2000, 157(2):290-292.
45. Laurin N., Feng Y., Ickowicz A., Pathare T., Malone M., Tannock R., et al. No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder. Mol Psychiatry 2007, 12(3):226-229.
46. Lee H.S., Kim S.H., Lee H.J., Kim L., Lee SK., Jang DW., et al. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia. Am J Med Genet 2002, 114(6):593-597.
47. Lee H.J., Lee H.S., Kim Y.K., Kim L., Lee MS., Jung IK., et al. D2 and D4 dopamine receptor gene polymorphisms and personality traits in a young Korean population. Am J Med Genet B Neuropsychiatr Genet 2003, 121(1):44-49.
48. Lee S.H., Ham B.J., Cho Y.H., Lee SM., Shim SH. Association study of dopamine receptor D2 TaqI A polymorphism and reward-related personality traits in healthy Korean young females. Neuropsychobiology 2007, 56(2-3):146-151.
49. Lin S.C., Wu P.L., Ko H.C., Wu JY., Huang SY., Lin WW., et al. Specific personality traits and dopamine, serotonin genes in anxiety-depressive alcoholism among Han Chinese in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(7):1526-1534.
50. Ling D., Niu T., Feng Y., Xing H., Xu X. Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. J Hum Genet 2004, 49(1):35-39.
51. Manchia M., Viggiano E., Tiwari A.K., Renou J., Jain U., De Luca V., et al. Smoking in adult attention deficit/hyperactivity disorder: interaction between 15q13 nicotinic genes and Temperament Character Inventory scores. World J Biol Psychiatry 2010, 11(2 Pt 2):506-510.
52. Mazei M.S., Pluto C.P., Kirkbride B., Pehek E.A. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res 2002, 936(1-2):58-67.
53. Mignone F., Gissi C., Liuni S., Pesole G. Untranslated regions of mRNAs. Genome Biol 2002, 3(3). reviewS0004.
54. Miller G.M., Madras B.K. Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002, 7(1):44-55.
55. Monakhov M., Golimbet V., Abramova L., Kaleda V., Karpov V. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr Res 2008, 100(1-3):302-307.
56. Müller S.E., Weijers H.G., Böning J., Wiesbeck G.A. Personality traits predict treatment outcome in alcohol-dependent patients. Neuropsychobiology 2008, 57(4):159-164.
57. Munafò M.R., Matheson I.J., Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007, 12(5):454-461.
58. Munafò M.R., Johnstone E.C., Murphy M.F., Aveyard P. Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial. Nicotine Tob Res 2009, 11(4):404-407.
59. Munro C.A., McCaul M.E., Wong D.F., et al. Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 2006, 59(10):966-974.
60. Neville M.J., Johnstone E.C., Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004, 23(6):540-545.
61. Nisoli E., Brunani A., Borgomainerio E., et al. D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 2007, 12(2):91-96.
62. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991, 48(7):648-654.
63. Noble E.P., Ozkaragoz T.Z., Ritchie T.L. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet 1998, 81(3):257-267.
64. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003, 116(1):103-125.
65. Peroutka S.J., Price S.C., Wilhoit T.L., Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 1998, 4(1):14-21.
66. Pohjalainen T., Rinne J.O., Nagren K., Lehikoinen P., Anttila K., Syvälahti EK., et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998, 3(3):256-260.
67. Pohjalainen T., Rinne J.O., Någren K. Sex differences in the striatal dopamine D2 receptor binding characteristics in vivo. Am J Psychiatry 1998, 155(6):768-773.
68. Ponce G., Jimenez-Arriero M.A., Rubio G., et al. The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry 2003, 18(7):356-360.
69. Pooley E.C., Fineberg N., Harrison P.J. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: case-control study and meta-analysis. Mol Psychiatry 2007, 12(6):556-561.
70. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira MA., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575.
71. Raygorodskiy D.Y. Practical psychodiagnostics. Principles and tests. Samara: Bahrah-M 2003, [372 p].
72. Ritchie T., Noble E.P. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 2003, 28(1):73-82.
73. Rowe D.C., Van den Oord E.J., Stever C., et al. The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry 1999, 4(6):580-586.
74. Samochowiec J., Rybakowski F., Czerski P., et al. Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the Temperament and Character Inventory in healthy volunteers. Neuropsychobiology 2001, 43(4):248-253.
75. Samochowiec J., Kucharska-Mazur J., Grzywacz A., Jabłoński M., Rommelspacher H., Samochowiec A., et al. Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett 2006, 410(1):1-5.
76. Sarkar G., Kapelner S., Grandy D.K., et al. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 1991, 11(1):8-14.
77. Sawada H., Shimohama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 2000, 24(1):143-147.
78. Serỳ O., Drtílková I., Theiner P., et al. Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 2006, 27(1-2):236-240.
79. Smillie L.D., Cooper A.J., Proitsi P., Powell JF., Pickering AD. Variation in DRD2 dopamine gene predicts Extraverted personality. Neurosci Lett 2010, 468(3):234-237.
80. Strous R.D., Nolan K.A., Lapidus R. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet 2003, 120B(1):29-34.
81. Thompson J., Thomas N., Singleton A., et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7(6):479-484.
82. Ueno S., Nakamura M., Mikami M., et al. Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol Psychiatry 1999, 4(6):552-557.
83. Uher R., Huezo-Diaz P., Perroud N., et al. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 2009, 9(4):225-233.
84. Vandenbergh D.J., Persico A.M., Hawkins A.L., Griffin CA., Li X., Jabs EW., et al. Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992, 14:1104-1106.
85. VanNess S.H., Owens M.J., Kilts C.D. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet 2005, 6:55.
86. van Dyck C.H., Malison R.T., Jacobsen L.K., Seibyl JP., Staley JK., Laruelle M., et al. Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 2005, 46(5):745-751.
87. van Strien T., Snoek H.M., van der Zwaluw C.S., Engels R.C. Parental control and the dopamine D2 receptor gene (DRD2) interaction on emotional eating in adolescence. Appetite 2010, 54(2):255-261.
88. Wacker J., Reuter M., Hennig J., Stemmler G. Sexually dimorphic link between dopamine D2 receptor gene and neuroticism-anxiety. NeuroReport 2005, 16(6):611-614.
89. Yoo H.J., Kim M., Ha J.H., et al. Biogenetic temperament and character and attention deficit hyperactivity disorder in Korean children. Psychopathology 2006, 39(1):25-31.
90. Zhang Y., Bertolino A., Fazio L., et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 2007, 104(51):20552-20557.
91. Zhu J., Bardo M.T., Bruntz R.C. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression. Eur J Neurosci 2007, 26(3):717-728.
92. Zuo Y., Gilbert D.G., Rabinovich N.E. DRD2-related TaqIA polymorphism modulates motivation to smoke. Nicotine Tob Res 2009, 11(11):1321-1329.